We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Outlook for Refurbished Medical Equipment Forecasts Growth over USD 9 Billion

By HospiMedica International staff writers
Posted on 06 Sep 2015
The authors of a new analysis of the global market for refurbished medical equipment forecast continued growth until the year 2019.

The report includes global forecasts for refurbished systems such as ultrasound, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), C-Arm, Nuclear Medical Imaging (NMI), and Catheterization laboratories. More...
The report focuses on the market penetration of refurbished medical devices, market development, market diversification, and a competitive assessment.

The market is expected to grow from 2014 to 2019 at a Compound Annual Growth Rate (CAGR) of 12.5%. The largest share of the market, 48%, was held by North America in 2014. The highest CAGR growth, 13.7% from 2014 through to 2019, is expected in the Asia-Pacific region. Growth in the Asia-Pacific region is expected to be driven by an increase in the number of hospitals, and surgical centers, increasing privatization, and an increasing focus of refurbished equipment manufacturers on this market. Drivers of growth in all regions include a rise in lifestyle diseases such as cancer, an aging population, and a rise in demand partly due to increasingly favorable regulatory scenarios and reduced insurance reimbursements for imaging exams. The market was held back by a lack of trust in the quality of refurbished medical products from some buyers.

GE Healthcare (Chalfont St Giles, Buckinghamshire, UK) Royal Philips Healthcare (Amsterdam, The Netherlands), and Siemens Healthcare (Erlangen, Germany) accounted for approximately 41% of the market.

The report was published by Research and Markets (Dublin, Ireland).

Related Links:

Research and Markets
Philips Healthcare
Siemens Healthcare



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Patient Monitoring System
AlarmSense
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.